Amsterdam, the Netherlands, September 1, 2015 - uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present at the NewsMakers in the Biotech Industry Conference, to be held September 10, 2015, at the Millennium Broadway Hotel and Conference Center in New York City, NY, USA.
Date: September 10, 2015
Time: 11:00 a.m. (EST)
Location: Millennium Broadway Hotel and Conference Center, New York City, NY, USA
Speaking for uniQure: Matt Kapusta, Chief Financial Officer
To access a simultaneous webcast of Mr. Kapusta’s presentation via the internet, log on to the “Events” section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure’s website for 30 days following the conference. Mr. Kapusta’s presentation will be available for download in PDF format immediately following the conference presentation in the “Events” section of the Media page of uniQure’s website at http://www.uniqure.com/news/calendar-of-events/.
About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com
uniQure:
Aicha Diba
Investor Relations
Direct : +31 20 240 6110
Main: +31 20 240 6000
a.diba@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or +1 781 235 3060
gschweitzer@macbiocom.com
Help employers find you! Check out all the jobs and post your resume.
